- Home
- TCBS vs CALC Comparison
TCBS vs CALC Comparison
Compare TCBS & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBS
- CALC
- Stock Information
- Founded
- TCBS 1934
- CALC 2011
- Country
- TCBS United States
- CALC United States
- Employees
- TCBS N/A
- CALC N/A
- Industry
- TCBS Banks
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- TCBS Finance
- CALC Health Care
- Exchange
- TCBS Nasdaq
- CALC Nasdaq
- Market Cap
- TCBS 48.8M
- CALC 22.9M
- IPO Year
- TCBS N/A
- CALC N/A
- Fundamental
- Price
- TCBS $16.76
- CALC $2.13
- Analyst Decision
- TCBS
- CALC Strong Buy
- Analyst Count
- TCBS 0
- CALC 2
- Target Price
- TCBS N/A
- CALC $14.50
- AVG Volume (30 Days)
- TCBS 4.6K
- CALC 38.7K
- Earning Date
- TCBS 08-12-2025
- CALC 08-11-2025
- Dividend Yield
- TCBS 0.95%
- CALC N/A
- EPS Growth
- TCBS N/A
- CALC N/A
- EPS
- TCBS 0.68
- CALC N/A
- Revenue
- TCBS $14,488,000.00
- CALC N/A
- Revenue This Year
- TCBS N/A
- CALC N/A
- Revenue Next Year
- TCBS N/A
- CALC N/A
- P/E Ratio
- TCBS $24.63
- CALC N/A
- Revenue Growth
- TCBS 54.08
- CALC N/A
- 52 Week Low
- TCBS $13.52
- CALC $1.42
- 52 Week High
- TCBS $19.40
- CALC $5.97
- Technical
- Relative Strength Index (RSI)
- TCBS 65.38
- CALC 48.14
- Support Level
- TCBS $16.20
- CALC $1.59
- Resistance Level
- TCBS $19.40
- CALC $1.69
- Average True Range (ATR)
- TCBS 0.51
- CALC 0.15
- MACD
- TCBS 0.06
- CALC 0.01
- Stochastic Oscillator
- TCBS 22.58
- CALC 46.51
About TCBS Texas Community Bancshares Inc.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.